Patent Assignment
Reel/Frame 040465/0781
Assignment of Assignor's Interest
Recorded: 2016-11-30
Pages: 3
Assignor
FREIER, SUSAN M.
Executed: 2005-04-20
Assignee
ISIS PHARMACEUTICALS, INC.
2292 FARADAY AVENUE, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(2)
Antisense Modulation of Apolipoprotein B-Expression
Patent:
44,760 →
Application:
13/629,214 →
Antisense Modulation of Apolipoprotein B-Expression
Application:
14/175,889 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 31, 2016
From: GENZYME CORPORATION
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 038753/0455 →
Assignment of Assignor's Interest
May 31, 2016
From: IONIS PHARMACEUTICALS, INC.
To: KASTLE THERAPEUTICS, LLC.
Reel/Frame 038754/0487 →
Assignment of Assignor's Interest
Nov 30, 2016
From: CROOKE, ROSANNE; GRAHAM, MARK
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 040465/0720 →
Assignment of Assignor's Interest
Nov 30, 2016
From: ISIS PHARMACEUTICALS, INC.
To: GENZYME CORPORATION
Reel/Frame 040465/0810 →
Security Interest
Feb 1, 2017
From: KASTLE THERAPEUTICS, LLC; KASTLE THERAPEUTICS HOLDINGS, LLC; KASTLE THERAPEUTICS INTERMEDIATE, LLC
To: COMERICA BANK
Reel/Frame 041148/0542 →